Real-world experience of cladribine treatment in relapsing-remitting multiple sclerosis: A Danish nationwide studyPer Soelberg Sørensen, Melinda Magyari, Peter Vestergaard Rasmussen et al.|Multiple Sclerosis and Related Disorders|2022Cited by 42
Risk of T2 lesions when discontinuing fingolimod: a nationwide predictive and comparative studyMalthe Faurschou Wandall‐Holm, Melinda Magyari, Alex Heick et al.|Brain Communications|2023Cited by 4